Share
Journal Information
Most often read
7543
The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from VietnamHai-Binh Bui, Hong-Thinh Lai, Thanh-Lam Nguyen, Thuy-Duong Vu, Nhat-Le Bui, Van-Hung Nguyen, Thi-To-Chau Tran, Thi-Phuong-Thuy Nguyen, ... Dinh-Toi Chu
Reumatol Clin. 2024;20:128-35
7543
3084
Spontaneous pneumomediastinum: An extra muscular manifestation of anti-MDA5 dermatomyositis. Report of 2 casesPablo Arango Guerra, Santiago Monsalve Yepes, Andrés Chavarriaga Restrepo, Carlos Jaime Velasquez Franco
Reumatol Clin. 2024;20:218-22
3084
1244
Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practiceJordi Gratacós-Masmitja, Emma Beltrán Catalán, José Luis Álvarez Vega, Ana Urruticoechea-Arana, Concepción Fito, Francisco Maceiras, Joaquín María Belzunegui Otano, Julia Fernández Melón, ... on behalf of the PREVAIL team
Reumatol Clin. 2024;20:24-31
1244
Full text access
Open Article
301
VEXAS syndrome: Clinical manifestations, diagnosis, and treatmentMichelle Patricia Loeza-Uribe, Andrea Hinojosa-Azaola, Beatriz E. Sánchez-Hernández, José C. Crispín, Elia Apodaca-Chávez, Marcela A. Ferrada, Eduardo Martín-Nares
Reumatol Clin. 2024;20:47-56
301
Open Article
115
Disseminated gonococcal disease in pediatrics: Case report and review of the literatureAna K. Leos-Leija, Rocío C. Calderón-Zamora, Ana V. Villarreal-Treviño, Fernando García-Rodríguez, Manuel E. de La O-Cavazos, Nadina E. Rubio-Pérez
Reumatol Clin. 2024;20:43-4
115
Open Article
114
The patient journey of fibromyalgia in Latin AmericaTeresa Otón, Osvaldo Daniel Messina, Daniel G. Fernández Ávila, Manuel Robles San Román, Darío Mata, Constanza Arguissain, Jorge Miguel Galindo Guzmán, Marina Pérez, ... Grupo Fibrojourney Latam
Reumatol Clin. 2024;20:32-42
114
Open Article
104
Termination of pregnancy in lupus nephritis: A bioethical analysis with the integrative methodTábata Cano-Gámez, Adriana Concepción Lobato-Belmonte, Ingris Peláez-Ballestas, Gabriel Medrano-Ramírez, Juan Carlos de León-Carbajal, Amaranta Manrique de Lara
Reumatol Clin. 2024;20:20-3
104
Open Article
96
Entities inside one another: VEXAS, a matryoshka-type diseaseSilvia Suárez-Díaz, Carmen Yllera-Gutiérrez, Claudia Morán-Castaño, Luis Caminal-Montero
Reumatol Clin. 2024;20:57-8
96
Open Article
71
DKK-1 in psoriatic arthritis: Correlation with disease activity and enthesopathyMarian Aziz Wahba Abdo Wahba, Nagat Mohamed El-Gazzar, Radwa Mahmoud Elsharaby, Samar Abdalhamed Tabra
Reumatol Clin. 2024;20:14-9
71
Open Article
69
Osteoporosis in psoriatic arthritis: Risk factors, insufficiency fractures and its association with the disease activityMaría Paz Martínez-Vidal, Vega Jovani, José Raúl Noguera-Pons, Antonio Álvarez-Cienfuegos
Reumatol Clin. 2024;20:8-13
69
Open Article
68
CXCL10 as a biomarker of interstitial lung disease in patients with rheumatoid arthritisYasmine S. Makarem, Elzahraa A. Ahmed, Marwa Makboul, Shimaa Farghaly, Naima Mostafa, Randa A. El Zohne, Samar H. Goma
Reumatol Clin. 2024;20:1-7
68
Open Article
64
VEXAS syndrome: A 2-case series reportAdrián Mayo-Juanatey, María José Fernández-Llavador, María del Mar Fernández-Garcés, Elia Valls-Pascual, Juan José Alegre-Sancho
Reumatol Clin. 2024;20:341-4
64
62
Pigmentation disorders as a guide sign of autoimmune diseasesBeatriz Clemente Hernández, Itziar Muelas Rives, Adrián Ballano Ruiz, Tamara Gracia Cazaña
Reumatol Clin. 2024;20:45-6
62
Open Article
31
Usefulness of ultrasound in clinical decision-making in rheumatology clinical practice: A single-center longitudinal studyMarta Serrano-Warleta, Aliuska Palomeque-Vargas, Rosa Manzo, Boris Blanco-Cáceres, Mónica Vazquez-Díaz, Carlos Guillen-Astete
Reumatol Clin. 2024;20:147-9
31
18
Impact of the COVID-19 pandemic on psychosocial health in rheumatic patients: A longitudinal studyLaura Cano-García, Sara Manrique-Arija, Rocío Redondo-Rodríguez, Marta Vera-Ruiz, Jose Manuel Lisbona-Montañez, Arkaitz Mucientes-Ruiz, Aimara García-Studer, Fernando Ortiz-Marquez, ... Antonio Fernández-Nebro
Reumatol Clin. 2024;20:297-304
18
12
SER recommendations on treatment of refractory Behçet's syndromeClara Moriano Morales, Jenaro Graña Gil, Noé Brito García, José Luis Martín Varillas, Vanesa Calvo del Río, Patricia Moya Alvarado, Francisco Javier Narváez García, Gerard Espinosa, ... Julio Suárez Cuba
Reumatol Clin. 2024;20:204-17
12
7
Quality of life of patients with rheumatic diseasesLourdes Villalobos-Sánchez, Boris Blanco-Cáceres, Javier Bachiller-Corral, María Teresa Rodríguez-Serrano, Mónica Vázquez-Díaz, Pablo Lázaro y de Mercado
Reumatol Clin. 2024;20:59-66
7
7
Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual riskCristiana Sieiro Santos, Maria Miguel Oliveira, Paulo Ney Solari, Pedro Mateus, Maria José Santos, Hector Corominas, Carolina Álvarez Castro, Elvira Díez Álvarez
Reumatol Clin. 2024;20:229-36
7
6
Effect of combined treatment with prednisone and methotrexate versus prednisone alone over laboratory parameters in giant cell arteritisInes Perez-Sancristobal, Paula Alvarez-Hernandez, Cristina Lajas-Petisco, Benjamin Fernandez-Gutierrez
Reumatol Clin. 2024;20:108-12
6
5
Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023Carlos Abud-Mendoza, Francisco Javier Aceves-Ávila, César Alejandro Arce-Salinas, José Álvarez Nemegyei, Leonor Barile-Fabris, Sergio Durán-Barragán, Diana Elsa Flores-Alvarado, Eufrates Hernández-Núñez, ... César Pacheco-Tena
Reumatol Clin. 2024;20:263-80
5
Publish in
Reumatología Clínica
Free access articles
Reumatol Clin. 2024;20:24-31
Reumatol Clin. 2023;19:565-70
Reumatol Clin. 2023;19:319-27